These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25534589)

  • 1. Editorial comment.
    Pastuszak AW
    J Urol; 2015 Feb; 193(2):414. PubMed ID: 25534589
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Mearini L
    J Urol; 2015 Feb; 193(2):414. PubMed ID: 25534585
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum Testosterone Levels and Prostate Cancer Risk: A Single Post-Hoc Testosterone Measurement is Not Informative.
    Loughlin KR
    J Urol; 2019 Jan; 201(1):40-41. PubMed ID: 30130546
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Prasad SM; Keane TE; Bennett CL
    Urology; 2012 Jul; 80(1):168. PubMed ID: 22608794
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    Nelson PS
    Urology; 2012 Jul; 80(1):180-1; author reply 181. PubMed ID: 22748874
    [No Abstract]   [Full Text] [Related]  

  • 6. Testosterone and prostate cancer.
    Tubaro A
    Eur Urol; 2007 Feb; 51(2):293-5. PubMed ID: 17034931
    [No Abstract]   [Full Text] [Related]  

  • 7. New concepts regarding the relationship of testosterone and prostate cancer.
    Morgentaler A
    Future Oncol; 2007 Apr; 3(2):123-6. PubMed ID: 17381410
    [No Abstract]   [Full Text] [Related]  

  • 8. Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer.
    Carpenter WR; Robinson WR; Godley PA
    J Natl Cancer Inst; 2008 Feb; 100(3):158-9. PubMed ID: 18230791
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis.
    Shariat SF; Lamb DJ; Roehrborn CG; Slawin KM
    Arch Intern Med; 2008 Jan; 168(2):235-6. PubMed ID: 18227373
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial Comment to Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?
    Sakamoto S
    Int J Urol; 2015 Jan; 22(1):134. PubMed ID: 25351852
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of orchidectomy on serum concentrations of testosterone and dihydrotestosterone in patients with prostatic cancer.
    Røhl HF; Beuke HP
    Scand J Urol Nephrol; 1992; 26(1):11-4. PubMed ID: 1631501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment.
    Zlotta AR
    J Urol; 2012 May; 187(5):1606; discussion 1606-7. PubMed ID: 22425082
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.
    Sciarra A
    Eur Urol; 2009 Feb; 55(2):320-1. PubMed ID: 18838210
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prolactin and prostatic cancer. Modification of testosterone serum levels in estrogen-induced hyperprolactinemia by bromocriptine].
    Maganto E; Mayayo T; Mateos JA; Verdú F; Escudero Barrilero A
    Actas Urol Esp; 1983; 7(4):289-94. PubMed ID: 6624577
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma testosterone and sex hormone transport globulin in patients with prostatic carcinoma under treatment].
    Daponte DP; Pidcock M; Robinson MR; Smith PH
    Actas Urol Esp; 1982; 6(1):17-20. PubMed ID: 7200715
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of knowing testosterone levels in patients with prostate cancer.
    Kirby M
    BJU Int; 2014 Aug; 114(2):164-5. PubMed ID: 25070137
    [No Abstract]   [Full Text] [Related]  

  • 17. Pretreatment testosterone and metastatic relapse after prostate irradiation.
    Daniell HW
    Urology; 1999 Jan; 53(1):241. PubMed ID: 9886624
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.
    Klap J; Schmid M; Loughlin KR
    J Urol; 2015 Feb; 193(2):403-13. PubMed ID: 25260832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer].
    Hájek J; Hanselová M; Vrubel F
    Vnitr Lek; 1981 Sep; 27(9):852-60. PubMed ID: 7293030
    [No Abstract]   [Full Text] [Related]  

  • 20. Soy and cancer: seeds of answers, but no fruit.
    Christensen D
    J Natl Cancer Inst; 2005 Oct; 97(20):1494-5. PubMed ID: 16234560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.